Inhaled Corticosteroids for the Treatment of Transient Tachypnea of the Newborn
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Transient Tachypnea of the Newborn (TTN) is a common respiratory disorder affecting late
preterm and term babies caused by lung edema resulting from delayed absorption of fetal
alveolar lung fluid.
The investigators hypothesize that ENAC expression will be up-regulated as a result of
administration of corticosteroids. This effect will lead to enhanced absorption of fetal lung
fluid finally treating TTN. The aim of our study will be to evaluate whether inhaled
corticosteroids reduce respiratory distress and morbidity in late preterm and term neonates
presenting with TTN.